Clinical Trials Browser

Phase 1/2 × Small Cell Lung Carcinoma × Doxorubicin × Clear all

NCT02261805 2018-04-23

A Phase I/II Study of Ganetespib in Combination With Doxorubicin

Phase 1/2 Terminated

11 enrolled 7 charts

Neoplasms, Small Cell Lung Carcinoma